The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 2
- 2 new
- Median first-year cost
- $1,491,476
- $2,982,951 in all
- Institutions
- 2
- 2 contact PIs
Awards by fiscal year
0
0
0
0
0
2
0
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- 4E THERAPEUTICS INC.1
- KNOPP BIOSCIENCES, LLC1
Most frequent study sections
- Special Emphasis Panel (ZNS1 SRB-H (07))2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2019 | Selective Kv7.2/3 activators for the treatment of neuropathic pain1U44NS115732-01 | Resnick, LynnSignore, Armando | KNOPP BIOSCIENCES, LLC, PA | First-year cost $1,493,500 | Study section ZNS1 |
| FY2019 | Development and Optimization of MNK Inhibitors for the Treatment of Neuropathic Pain1U44NS115692-01 | Sahn, James Jeffrey | 4E THERAPEUTICS INC., TX | First-year cost $1,489,451 | Study section ZNS1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.